Jennifer R Cracchiolo1, Anne F Klassen2, Danny A Young-Afat3, Claudia R Albornoz4, Stefan J Cano5, Snehal G Patel1, Andrea L Pusic6,7, Evan Matros8. 1. Head and Neck Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York. 2. Department of Pediatrics, McMaster University, Hamilton, Ontario, Canada. 3. Department of Plastic and Reconstructive Surgery, Amsterdam University Medical Centers, VU University Medical Center, Amsterdam, The Netherlands. 4. Department of Plastic Surgery, Las Condes Clinic, Santiago, Chile. 5. Modus Outcomes, Letchworth Garden City, United Kingdom. 6. Plastic and Reconstructive Surgery Service, Department of Surgery, Brigham and Women's Hospital, Boston, Massachusetts. 7. Department of Surgery, Harvard University, Boston, Massachusetts. 8. Plastic and Reconstructive Surgery Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.
Abstract
BACKGROUND: Existing patient-reported outcome measures (PROMs) used to assess patients with head and neck cancer have methodologic and content deficiencies. Herein, the development of a PROM that meets a range of clinical and research needs across head and neck oncology is described. METHODS: After development of the conceptual framework, which involved a literature review, semistructured patient interviews, and expert input, patients with head and neck cancer who were treated at Memorial Sloan Kettering Cancer Center were recruited by their surgeon. The FACE-Q Head and Neck Cancer Module was completed by patients in the clinic or was sent by mail. Rasch measurement theory analysis was used for item selection for final scale development and to examine reliability and validity. Scale scores for surgical defect and adjuvant therapy were compared with the cohort average to assess clinical applicability. RESULTS: The sample consisted of 219 patients who completed the draft scales. Fourteen independently functioning scales were analyzed. Item fit was good for all 102 items, and all items had ordered thresholds. Scale reliability was acceptable (person separation index was >0.75 for all scales; Cronbach α values were >.87 for all scales; test-retest ranged from 0.86 to 0.96). The scales performed well in a clinically predictable way, demonstrating functional and psychosocial differences across disease sites and with adjuvant therapy. CONCLUSIONS: The scales forming the FACE-Q Head and Neck Cancer Module were found to be clinically relevant and scientifically sound. This new PROM now is validated and ready for use in research and clinical care.
BACKGROUND: Existing patient-reported outcome measures (PROMs) used to assess patients with head and neck cancer have methodologic and content deficiencies. Herein, the development of a PROM that meets a range of clinical and research needs across head and neck oncology is described. METHODS: After development of the conceptual framework, which involved a literature review, semistructured patient interviews, and expert input, patients with head and neck cancer who were treated at Memorial Sloan Kettering Cancer Center were recruited by their surgeon. The FACE-Q Head and Neck Cancer Module was completed by patients in the clinic or was sent by mail. Rasch measurement theory analysis was used for item selection for final scale development and to examine reliability and validity. Scale scores for surgical defect and adjuvant therapy were compared with the cohort average to assess clinical applicability. RESULTS: The sample consisted of 219 patients who completed the draft scales. Fourteen independently functioning scales were analyzed. Item fit was good for all 102 items, and all items had ordered thresholds. Scale reliability was acceptable (person separation index was >0.75 for all scales; Cronbach α values were >.87 for all scales; test-retest ranged from 0.86 to 0.96). The scales performed well in a clinically predictable way, demonstrating functional and psychosocial differences across disease sites and with adjuvant therapy. CONCLUSIONS: The scales forming the FACE-Q Head and Neck Cancer Module were found to be clinically relevant and scientifically sound. This new PROM now is validated and ready for use in research and clinical care.
Authors: Ethan Basch; Allison M Deal; Amylou C Dueck; Howard I Scher; Mark G Kris; Clifford Hudis; Deborah Schrag Journal: JAMA Date: 2017-07-11 Impact factor: 56.272
Authors: Wess A Cohen; Claudia R Albornoz; Peter G Cordeiro; Jennifer Cracchiolo; Elizabeth Encarnacion; Meghan Lee; Michele Cavalli; Snehal Patel; Andrea L Pusic; Evan Matros Journal: Plast Reconstr Surg Date: 2016-12 Impact factor: 4.730
Authors: Mark El-Deiry; Gerry F Funk; Sarvi Nalwa; Lucy H Karnell; Russell B Smith; John M Buatti; Henry T Hoffman; Gerry H Clamon; Scott M Graham; Douglas K Trask; Kenneth J Dornfeld; Min Yao Journal: Arch Otolaryngol Head Neck Surg Date: 2005-10
Authors: Julia R Van Liew; Alan J Christensen; M Bryant Howren; Lucy Hynds Karnell; Gerry F Funk Journal: Health Psychol Date: 2013-06-17 Impact factor: 4.267
Authors: Bhishamjit S Chera; Avraham Eisbruch; Barbara A Murphy; John A Ridge; Patrick Gavin; Bryce B Reeve; Deborah Watkins Bruner; Benjamin Movsas Journal: J Natl Cancer Inst Date: 2014-07-08 Impact factor: 13.506
Authors: Claudia R Albornoz; Andrea L Pusic; Patrick Reavey; Amie M Scott; Anne F Klassen; Stefan J Cano; Peter G Cordeiro; Evan Matros Journal: Clin Plast Surg Date: 2012-11-26 Impact factor: 2.017
Authors: Sallie M Long; Annu Singh; Amy L Tin; Bridget O'Hara; Marc A Cohen; Nancy Lee; David G Pfister; Tony Hung; Richard J Wong; Andrew J Vickers; Cherry L Estilo; Jennifer R Cracchiolo Journal: JAMA Otolaryngol Head Neck Surg Date: 2022-08-01 Impact factor: 8.961
Authors: Joseph C Dort; S Nicole Culos-Reed; Julia T Daun; Rosie Twomey; Lauren C Capozzi; Trafford Crump; George J Francis; T Wayne Matthews; Shamir Chandarana; Robert D Hart; Christiaan Schrag; Jennifer Matthews; C David McKenzie; Harold Lau Journal: Pilot Feasibility Stud Date: 2022-05-27
Authors: Robert J Allen; Jonas A Nelson; Thais O Polanco; Meghana G Shamsunder; Ian Ganly; Jay Boyle; Evan Rosen; Evan Matros Journal: Plast Reconstr Surg Date: 2020-12 Impact factor: 5.169
Authors: Rachel A Anolik; Jonas A Nelson; Evan B Rosen; Joseph Disa; Evan Matros; Robert J Allen Journal: Plast Reconstr Surg Glob Open Date: 2021-09-17
Authors: Rebecca L Venchiarutti; Masako Dunn; Emma Charters; Kai Cheng; Catriona Froggatt; Payal Mukherjee; Christine Wallace; Dale Howes; David Leinkram; Jasvir Singh; Kevin Nguyen; Tsu-Hui Hubert Low; Sydney Ch'ng; James Wykes; Raymond Wu; Jonathan R Clark Journal: Cancers (Basel) Date: 2022-09-20 Impact factor: 6.575
Authors: Toral S Vaidya; Shoko Mori; Nima Khoshab; Stephen W Dusza; Thomas Bander; Evan Matros; Anthony M Rossi; Kishwer S Nehal; Erica H Lee Journal: Plast Reconstr Surg Glob Open Date: 2019-09-30
Authors: David Macias; Brittany N Hand; Patrik Pipkorn; Amy M Williams; Steven S Chang; Joseph Zenga; Marci L Nilsen; Bethany A Rhoten; Andrew T Huang; Nosayaba Osazuwa-Peters; Stacey Maurer; Wendy Balliet; Hong Li; Kenneth J Ruggiero; Katherine R Sterba; Evan M Graboyes Journal: Front Psychol Date: 2021-12-10
Authors: Olga Strachna; Marc A Cohen; Monica M Allison; David G Pfister; Nancy Y Lee; Richard J Wong; Sean M McBride; Raia R Mohammed; Elizabeth Kemeny; Fernanda C G Polubriaginof; Alyse Kassa; Michael Hannon; Jennifer R Cracchiolo Journal: Cancer Date: 2020-10-27 Impact factor: 6.860